MedX Health of Mississauga, Ontario, has signed an exclusive distribution agreement with Technology4Medicine, a newly formed laser company in San Clemente, CA. Technology4Medicine will sell MedX Health's newest laser product, Oralase, in the U.S. once the product receives FDA marketing clearance.
Oralase is a low-level laser therapy (LLLT) device designed to alleviate pain and accelerate tissue repair following dental procedures. MedX has already applied for FDA clearance for Oralase.
"MedX is already well-established in the rehabilitation market, offering innovative laser and light therapy products that have successfully treated pain, sports injuries, and other conditions," said Steve Guillen, president and CEO of MedX Health in a press release. "We believe our products can offer patients with acute and chronic wounds a noninvasive, drug-free solution, and we fully intend to pursue these indications aggressively."
